Moloney murine leukemia virus-induced lymphomas in p53-Dencient mice: Overlapping pathways in tumor development?

Journal of Virology

Volumn 70, Issue 4, 1996, Pages 2095-2100

  Baxter, E W ^a   Blyth, K ^a   Donehower, L A ^b   Cameron, E R ^a   Onions, D E ^a   Neil, J C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL CELL; ARTICLE; GENOTYPE; LYMPHOMA; MALIGNANT TRANSFORMATION; MOLONEY LEUKEMIA ONCOVIRUS; MOUSE; MURINE LEUKEMIA VIRUS; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROVIRUS; THYMUS LYMPHOMA; VIRUS INDUCTION; VIRUS INFECTION;

ALLELES; ANIMALS; BASE SEQUENCE; DNA PRIMERS; GENE FREQUENCY; GENE REARRANGEMENT; GENES, MYC; GENETIC HETEROGENEITY; GENOTYPE; LYMPHOMA; MICE; MICE, TRANSGENIC; MINK CELL FOCUS-INDUCING VIRUSES; MOLECULAR SEQUENCE DATA; MOLONEY MURINE LEUKEMIA VIRUS; MUTAGENESIS, INSERTIONAL; PHENOTYPE; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-PIM-1; PROVIRUSES; RETROVIRIDAE INFECTIONS; THYMUS NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS;

EID: 0029967663     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.4.2095-2100.1996     Document Type: Article

References (42)

1. Acton, D., J. Domen, H. Jacobs, M. Maar, S. Korsmeyer, and A. Berns. 1992. Collaboration of pim-1 and bcl-2 in lymphomagenesis. Curr. Top. Microbiol. Immunol. 182:293-298.
2. Ben-David, Y., V. R. Prideaux, V. Chow, S. Benchimol, and A. Bernstein. 1988. Inactivation of the p53 oncogene by internal deletion or retroviral integration in erythroleukemia cell lines induced by Friend murine leukemia virus. Oncogene 3:179-185.
3. Bergeron, D., J. Houde, L. Poliquin, B. Barbeau, and E. Rassart. 1993. Expression and DNA rearrangement of proto-oncogenes in Cas-Br-E-induced non-T, non-B cell leukemias. Leukemia 7:954-962.
4. Bernard, O., S. Cory, S. Gerondakis, E. Webb, and J. M. Adams. 1983. Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO J. 2:2375-2383.
5. Bissonette, R. P., F. Echeverri, A. Mahboubi, and D. R. Green. 1992. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature (London) 359:552-556.
6. Blyth, K., A. Terry, M. O'Hara, E. W. Baxter, M. Campbell, M. Stewart, L. Donehower, D. E. Onions, J. C. Neil, and E. R. Cameron. 1995. Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss. Oncogene 10:1717-1723
7. Clark, S. S., E. Chen, M. Fizzotti, O. N. Witte, and V. Malkovska. 1993. BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets. J. Virol. 67:6033-6046.
8. Clarke, A. R., C. A. Purdie, D. J. Harrison, R. G. Morris, C. C. Bird, M. L. Hooper, and A. H. Wyllie. 1993. Thymocyte apoptosis induced by p53-dependent and independent pathways Nature (London) 362:849-852.
9. Cuypers, H. T., G. Selten, W. Quint, M. Zijlstra. E. R. Maandag, W. Boelens, P. van Wezenbeek, C. Melief, and A. Berns. 1984. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region Cell 37:141-150.
10. Cuypers, H. T., G. Selten, M. Zjilstra, R. de Goede, C. Melief, and A. Berns. 1986. Tumor progression in murine leukemia virus-induced T-cell lymphomas: monitoring clonal selections with viral and cellular probes. J. Virol. 60:230-231.
11. Donehower, L. A., M. Harvey, B. L. Slagle, M. J. McArthur, C. A. Montgomery, J. S. Butel, and A. Bradley. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature (London) 356:215-221.
12. Elson, A., C. Deng, J. Campos-Torres, L. A. Donehower, and P. Leder. 1995. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice Oncogene 11:181-190.
13. Flubacher, M. M., S. E. Bear, and P. N. Tsichlis. 1994. Replacement of interleukin-2 (IL-2)-generated mitogenic signals by a mink cell focus-forming (MCF) or xenotropic virus-induced IL-9-dependent autocrine loop: implications for MCF virus-induced leukemogenesis J. Virol. 68:7709-7716.
14. Haupt, Y., W. S. Alexander, G. Barri, S. P. Klinken, and J. M. Adams. 1991. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eμ-myc transgenic mice. Cell 65:753-763.
15. Hedrick S. M., D. I. Cohen, E. A. Nielsen, and M. M. Davis. 1984. Isolation of cDNA clones encoding T cell-specific membrane associated proteins. Nature (London) 308:149-153.
16. Hollstein, M., D. Sidransky, B. Vogelstein, and C. C. Harris. 1991. p53 mutations in human cancer. Science 235:49-53
17. Howard, J. C., S. Yousefi, G. Cheong, A. Bernstein, and Y. Ben-David. 1993. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukaemias induced by F-MuLV. Oncogene 8:2721-2729.
18. Hsu, B., M. C. Marin, A. K. El-Naggar, L. C. Stephens, S. Brisbay, and T. J. McDonnell. 1995. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis. Oncogene 11:175-179.
19. Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. 1991 Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304-6311.
20. Kemp, C. J., L. A. Donehower, A. Bradley, and A. Balmain. 1993. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumours. Cell 74:813-822.
21. Lane, D. P. 1992 p53, guardian of the genome Nature (London) 358:15-16
22. Lazo, P. A., A. J. P. Klein-Szanto, and P. N. Tsichlis. 1990. T-cell lymphoma lines derived from rat thymomas induced by Moloney murine leukemia virus: phenotypic diversity and its implications J. Virol. 64:3948-3959.
23. Lowe, S., T. Jacks, D. Housman, and H. E. Ruley. 1994. Abrogation of oncogene associated apoptosis allows transformation p53-deficient cells. Proc. Natl. Acad. Sci. USA 91:2026-2030.
24. Marcu, K. B., J. Banerji, N. A. Penncavage, R. Lang, and N. Arnheim. 1980. 5′ flanking region of immunoglobulin heavy chain constant region genes displays length heterogeneity in germlines of inbred mouse strains. Cell 22:187-196.
25. Marin, M. C., B. Hsu, R. E. Meyn, L. A. Donehower, A. K. El-Naggar, and T. J. McDonnell. 1994. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene 9:3107-3112.
26. Mowat, M., A. Cheng, N. Kimura, A. Bernstein, and S. Benchimol. 1985. Rearrangements of the cellular p53 gene in erythroleukaemic cells transformed by Friend virus. Nature (London) 314:633-536.
27. Munroe, D. G., J. W. Peacock, and S. Benchimol. 1990. Inactivation of the cellular p53 gene is a common feature of Friend virus-induced erythroleukemia: relationship of inactivation to dominant transforming activity Mol. Cell. Biol 10:3307-3313.
28. Neil, J. C., D. Hughes, R. McFarlane, N. M. Wilkie, D. E. Onions. G. Lees, and O. Jarrett. 1984 Transduction and rearrangement of the myc gene by feline leukaemia virus in naturally occurring T-cell leukaemias. Nature (London) 308:814-820.
29. Poirier, Y., C. Kozak, and P. Jolicoeur. 1988. Identification of a common helper provirus integration site in Abelson murine leukemia virus-induced lymphoma DNA. J. Virol. 62:3985-3992.
30. Purdie, C. A., D. J. Harrison, A. Peter, L. Dobbie, S. White, S. E. M. Howie, D. M. Salter, C. C. Bird, A. H. Wyllie, M. L. Hooper, and A. R. Clarke. 1994 Tumour incidence, spectrum and ploidy in mice with a large deletion in the p53 gene. Oncogene 9:603-609.
31. Rein, A. 1982 Interference grouping of murine leukemia viruses: a distinct receptor for the MCF-recombinant viruses in mouse cells. Virology 120:251-257
32. Renauld, J. C., A. Vink, J. Louahed, and J. van Snick. 1995. Interleukin 9 is a major anti-apoptotic factor for thymic lymphomas. Blood 85:1300-1305
33. Selten, G., H. T. Cuypers, M. Zijlstra, C. Melief, and A. Berns. 1984 Involvement of c-myc in MuLV-induced T-cell lymphomas in mice: frequency and mechanisms of activation EMBO J. 3:3215-3222.
34. Stewart, M. A., E. Cameron, S. Toth, M. Campbell, R. McFarlane, D. Onions, and J. C. Neil. 1993. Conditional expression and oncogenicity of a human c-myc transgene linked to a human CD2 dominant control region Int. J. Cancer 53:1023-1030.
35. Strasser, A., A. W. Harris, M. L. Bath, and S. Cory. 1990. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature (London) 348:331-333.
36. Taya, Y., S. Mizusawa, and S. Nishimura. 1986. Nucleotide sequence of the coding region of the mouse N-myc gene. EMBO J. 5:1215-1219
37. Tsukada, T., Y. Tomooka, S. Takai, Y. Ueda, S. Nishikawa, T. Yagi, T. Tokanaga, N. Takeda, Y. Suda, S. Abe, I. Matsuo, Y. Ikawa, and S. Aizawa. 1993. Enhanced proliferative potential in culture of cells from p53-deficient mice. Oncogene 8:3313-3322.
38. van der Putten, H., W. Quint, J. van Raaij, E. R. Maandag, I. M. Verma, and A. Berns. 1981. M-MuLV-induced leukemogenesis: integration and structure of recombinant proviruses in tumors. Cell 24:729-739.
39. van Lohuizen, M., S. Verbeek, B. Seheijen, E. Wientjens, H. van der Gulden, and A. Berns. 1991. Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging. Cell 65:737-752.
40. Verbeek, S., M. van Lohuizen, M. van der Valk, J. Domen, G. Kraal, and A. Berns. 1991. Mice bearing the Eμ-myc and Eμ-pim-1 transgenes develop pre-B-cell leukemia prenatally. Mol. Cell Biol. 11:1176-1179.
41. Wolf, D. and V. Rotter. 1984. Inactivation of p53 gene expression by an insertion of Moloney murine leukemia virus-like DNA sequences. Mol. Cell Biol. 4:1402-1410.
42. Yonish-Rouach, E., D. Resnitsky, J. Lotem, L. Sachs, A. Kinichi, and M. Oren. 1991 Wild type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by IL-6. Nature (London) 352:345-347.